about
Influenza vaccination coverage in children with inflammatory bowel diseaseValue of Antral Nodularity for the Diagnosis of Helicobacter pylori Infection in Children.Genetic architecture differences between pediatric and adult-onset inflammatory bowel diseases in the Polish population.Immunogenicity of Pertussis Booster Vaccination in Children and Adolescents with Inflammatory Bowel Disease: A Controlled Study.Solitary Rectal Ulcer Syndrome in Children: A Case Series Study.Surgical Management of Crohn Disease in Children: Guidelines From the Paediatric IBD Porto Group of ESPGHAN.Overweight and obesity in children with newly diagnosed inflammatory bowel disease.Clear-Liquid Versus Low-Fibre Diet in Bowel Cleansing for Colonoscopy in Children: A Randomized Trial.A Two-Week Fecal Microbiota Transplantation Course in Pediatric Patients with Inflammatory Bowel Disease.Immunization Coverage in Children with Inflammatory Bowel Disease.Serotype-Specific Pneumococcal Status prior to PCV 13 Administration in Children and Adolescents with Inflammatory Bowel Disease.Inflammatory cytokines in exhaled breath condensate in children with inflammatory bowel diseases.Epidemiology of Inflammatory Bowel Disease among Children in PolandImmunogenecity of hepatitis A vaccine in pediatric patients with inflammatory bowel diseaseMonotherapy with infliximab versus combination therapy in the maintenance of clinical remission in children with moderate to severe Crohn disease"Cobblestone" Appearance of Esophagus: An Unusual Symptom of Pyloric StenosisImmunogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Pediatric Patients with Inflammatory Bowel Disease
P50
Q34274824-57436E58-45D1-4AE8-9E63-872AC670C7DAQ35794333-5B2A79CD-1F0F-4067-A710-2763EC39C0F7Q37529278-9E48416F-E80D-4E91-917F-02B9B1ECD9EDQ38844359-853206AB-0D27-45FB-BCDA-50E82D0829ABQ38931723-AFCBBE28-6D7E-4344-900B-944EE143CC48Q39165800-3D91C64A-9158-4F01-9EBF-71DE28F0BE0DQ45055913-251057E6-A0C5-4F19-9515-88C9EE667764Q47641552-B2F97A2E-D16A-4F8F-B708-2B794BD758E4Q49904375-5767CE28-06C3-4D85-B97D-BC5B55803CBDQ50079275-3110455B-71EB-4B90-80CE-589A5204DA7DQ51711435-A23A1655-4E68-4562-8011-200B119E8CEBQ54438557-F6C5B10D-4D5E-4491-9440-25669C26AFC0Q61848888-04C6F929-3D19-496B-BFB8-B94D7430B713Q84984314-A1AC492D-E140-4533-95B8-615ADC98B32AQ86486752-3EDDE96E-936F-417A-970E-3D95CCA81027Q86887759-C5AB6F82-323F-4133-9855-162B73D70631Q87204179-42415BB0-0AA1-45BD-B695-12758EC2BF92
P50
description
researcher ORCID ID = 0000-0003-4131-7373
@en
wetenschapper
@nl
name
Izabella Lazowska-Przeorek
@ast
Izabella Lazowska-Przeorek
@en
Izabella Lazowska-Przeorek
@es
Izabella Lazowska-Przeorek
@nl
type
label
Izabella Lazowska-Przeorek
@ast
Izabella Lazowska-Przeorek
@en
Izabella Lazowska-Przeorek
@es
Izabella Lazowska-Przeorek
@nl
prefLabel
Izabella Lazowska-Przeorek
@ast
Izabella Lazowska-Przeorek
@en
Izabella Lazowska-Przeorek
@es
Izabella Lazowska-Przeorek
@nl
P1153
26421705800
P31
P496
0000-0003-4131-7373